Rubidazon (BioDeep_00000831233)

   

Chemicals and Drugs Antibiotics


代谢物信息卡片


N-[(E)-1-[(2S,4S)-4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide

化学式: C34H35N3O10 (645.2322330000001)
中文名称: 佐柔比星
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)C6=CC=CC=C6)C)O)N)O
InChI: InChI=1S/C34H35N3O10/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43)/b36-16+

描述信息

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
D000970 - Antineoplastic Agents

同义名列表

4 个代谢物同义名

N-[(E)-1-[(2S,4S)-4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide; Daunomycin benzoylhydrazone; Rubidazone; Rubidazon



数据库引用编号

8 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • J Robert. [Pharmacokinetics of new anthracyclines]. Bulletin du cancer. 1988; 75(2):167-74. doi: . [PMID: 3282579]
  • R S Walters, H M Kantarjian, M J Keating, E H Estey, K B McCredie, E J Freireich. Intensive treatment of acute leukemia in adults 70 years of age and older. Cancer. 1987 Jul; 60(2):149-55. doi: 10.1002/1097-0142(19870715)60:2<149::aid-cncr2820600204>3.0.co;2-f. [PMID: 3474052]
  • J J Nguyen-Huu, P Turk, B Diquet. Determination of rubidazone and its metabolites in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography. Journal of chromatography. 1986 Aug; 380(2):455-61. doi: 10.1016/s0378-4347(00)83679-8. [PMID: 3760077]
  • N Kartner, M Shales, J R Riordan, V Ling. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer research. 1983 Sep; 43(9):4413-9. doi: NULL. [PMID: 6135505]
  • B A Peterson, C D Bloomfield, A J Gottlieb, M Coleman, M S Greenberg. 5-azactidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: a Cancer and Leukemia Group B pilot study. Cancer treatment reports. 1982 Mar; 66(3):563-6. doi: NULL. [PMID: 6174230]
  • E H Herman, R S Young. Acute cardiovascular alterations induced by low doses of adriamycin, rubidazone, and daunorubicin in the anesthetized beagle dog. Cancer treatment reports. 1979 Nov; 63(11-12):1771-9. doi: NULL. [PMID: 526912]
  • R S Benjamin, M J Keating, K B McCredie, G P Bodey, E J Freireich. A phase 1 and 2 trial of rubidazone in patients with acute leukemia. Cancer research. 1977 Dec; 37(12):4623-8. doi: NULL. [PMID: 270389]